Intertek Group plc has acquired Suplilab, enhancing its position in the rapidly growing Risk-based Quality Assurance market in Costa Rica's food safety and medical device testing sectors.
Target Information
Intertek Group plc has acquired Suplilab, a premier provider of food safety and medical device testing services based in San José, Costa Rica. Suplilab is recognized for its leading technical expertise in microbiology, water, and chemistry testing, and has established a strong position in rapid growth sectors characterized by high profit margins. The company employs 38 skilled professionals and reported revenues of £3.1 million in 2024.
This acquisition marks an important milestone for Intertek, as it allows the Group to tap into Central America's burgeoning demand for Risk-based Quality Assurance solutions, particularly in food safety and medical devices. The region's economic growth significantly enhances opportunities for quality assurance services that cater to the rising consumer demand for safer and sustainable food products.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The Costa Rican economy is experiencing rapid growth, positioning the country as a key player in the Central American market for Risk-based Quality Assurance services. The increa
Similar Deals
Edwards Lifesciences → JenaValve Technology
2026
Intertek Group plc
invested in
Suplilab
in 2025
in a Other deal
Disclosed details
Revenue: $4M